Send me a link:

*Text messaging rates may apply.

 Dow Down1.88% Nasdaq Down2.09%

NPS Pharmaceuticals, Inc. (NPSP)

-NasdaqGS
27.94 Down 1.35(4.61%) 3:59PM EDT
|After Hours : 27.94 0.00 (0.00%) 5:04PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 44,040   54,451   39,202   36,505  
Cost of Revenue1,877  1,981  1,077  473  
Gross Profit 42,163   52,470   38,125   36,032  
Operating Expenses
Research Development20,557  20,040  18,798  30,888  
Selling General and Administrative24,554  21,842  17,558  14,465  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,948) 10,588   1,769   (9,321)
Income from Continuing Operations
Total Other Income/Expenses Net418  (92)103  (30)
Earnings Before Interest And Taxes(2,530)10,496  1,872  (9,351)
Interest Expense4,035  2,550  2,959  3,034  
Income Before Tax(6,565)7,946  (1,087)(12,385)
Income Tax Expense11  178   -  4  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(6,576)7,768  (1,087)(12,389)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (6,576) 7,768   (1,087) (12,389)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (6,576) 7,768   (1,087) (12,389)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.